FDA Launches Program to Expedite Development of COVID-19 Treatments
On March 31, 2020, the U.S. Food and Drug Administration (FDA) announced the launch of…
Browsing: Federal
Aimed Alliance Releases Position Statement on Cannabidiol (CBD)
On March 30, 2020, Aimed Alliance published a position statement on products containing cannabidiol (CBD).…
CMS Clarifies Conditions of Enhanced Funding for State Medicaid Programs
On March 18, 2020, federal lawmakers enacted the Families First Coronavirus Response Act, which contained…
Senate Passes Coronavirus Stimulus Package, House to Vote Today
On March 25, 2020, the U.S. Senate unanimously passed S. 3548, titled the “Coronavirus Aid,…
CMS Issues Guidance on Prescription Drug Refills During the COVID-19 Outbreak
On March 24, 2020, the Center for Consumer Information & Insurance Oversight, an agency within…
CMS Issues Guidance on Telehealth Coverage and Use to Address COVID-19 Outbreak
On March 24, 2020, the Center for Consumer Information & Insurance Oversight, an agency within…
CMS Issues Guidance on Extending Deadlines for Health Insurance Premiums Amid COVID-19 Outbreak
On March 24, 2020, the Center for Consumer Information & Insurance Oversight, an agency within…
CMS Grants Program Flexibility to 11 More States for Medicaid and CHIP
On March 23, 2020, the Centers for Medicare & Medicaid Services (CMS) announced that the…
Surge in Unsubstantiated Claims that CBD May Prevent or Treat COVID-19
As the coronavirus pandemic continues to evolve, a new surge of unsubstantiated claims that cannabidiol…
HHS OIG Warns of Scammers Offering Fake COVID-19 Testing To Steal Medicare Beneficiaries’ Info
On March 23, 2020, the U.S. Department of Health and Human Services Office of Inspector…